Showing 1 - 12 results of 12 for search 'Thomas P. Lodise', query time: 0.04s Refine Results
  1. 1
    The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community

    The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community by Thomas P. Lodise, Michael Nowak, Mauricio Rodriguez

    Published 2022-04-01
    Get full text
    Article
  2. 2
    The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies

    The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Stud... by Sandy Estrada, Thomas P. Lodise, Glenn S. Tillotson, Dino Delaportas

    Published 2020-06-01
    Get full text
    Article
  3. 3
    Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals

    Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals by Thomas P. Lodise, Hoa Van Le, Kenneth LaPensee

    Published 2020-09-01
    Get full text
    Article
  4. 4
    Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway

    Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an... by Cristen Whittaker, Thomas P. Lodise, Ethan Nhan, Joseph Reilly

    Published 2020-06-01
    Get full text
    Article
  5. 5
    Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class

    Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class by Monique R. Bidell, Manjunath (Amit) P. Pai, Thomas P. Lodise

    Published 2020-12-01
    Get full text
    Article
  6. 6
    A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long?

    A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia col... by Thomas P. Lodise, Qi Zhao, Kyle Fahrbach, Patrick J. Gillard, Amber Martin

    Published 2018-12-01
    Get full text
    Article
  7. 7
    Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence

    Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence by Pierluigi Viale, Christian E. Sandrock, Paula Ramirez, Gian Maria Rossolini, Thomas P. Lodise

    Published 2023-06-01
    Get full text
    Article
  8. 8
    Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections

    Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections by Thomas P. Lodise, Nicole Gidaya Bonine, Jiatao Michael Ye, Henry J. Folse, Patrick Gillard

    Published 2019-08-01
    Get full text
    Article
  9. 9
    The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse

    The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse by Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael J. Rybak

    Published 2020-08-01
    Get full text
    Article
  10. 10
    Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections: A Real-World Retrospective Analysis

    Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections:... by Brittany Helton, Ashley MacWhinnie, Sarah Brooks Minor, Thomas P. Lodise, Kelly D. Rafferty, Steven L. Allison

    Published 2020-06-01
    Get full text
    Article
  11. 11
    Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

    Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections by Tristan Ferry, Tristan Ferry, Tristan Ferry, Tristan Ferry, Thomas P. Lodise, Jason C. Gallagher, Emmanuel Forestier, Sylvain Goutelle, Sylvain Goutelle, Vincent H. Tam, John F. Mohr, Claire Roubaud-Baudron, Claire Roubaud-Baudron

    Published 2020-12-01
    Get full text
    Article
  12. 12
    Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

    Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized... by Pranita D. Tamma, Maria Souli, Michael Billard, Joseph Campbell, Douglas Conrad, Damon W. Ellison, Beth Evans, Scott R. Evans, Kerryl E. Greenwood-Quaintance, Andrey A. Filippov, Holly S. Geres, Toshimitsu Hamasaki, Lauren Komarow, Mikeljon P. Nikolich, Thomas P. Lodise, Seema U. Nayak, Carmelle Norice-Tra, Robin Patel, David Pride, Janie Russell, Daria Van Tyne, Henry F. Chambers, Vance G. FowlerJr, Robert T. Schooley, for the Antibacterial Resistance Leadership Group

    Published 2022-12-01
    Get full text
    Article

Search Tools: